Concourse Financial Group Securities, Inc. Corbus Pharmaceuticals Holdings, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $0
 - Q2 2025
 
Number of Shares
0
              Previous 0
              
        
           NaN%
        
      
          
        Holding current value
$0
            Previous $0
            
        
           NaN%
        
      
          
        % of portfolio
100.0%
            Previous 100.0%
          
        Shares
	  29 transactions
	
  Others Institutions Holding CRBP
# of Institutions
4Shares Held
38.7KCall Options Held
0Put Options Held
0About Corbus Pharmaceuticals Holdings, Inc.
- Ticker CRBP
 - Exchange NASDAQ
 - Sector Healthcare
 - Industry Biotechnology
 - Shares Outstandng 125,268,000
 - Market Cap $1.52B
 - Description
 - Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...